TriSalus Life Sciences (TLSIW) Total Current Liabilities (2021 - 2026)

TriSalus Life Sciences (TLSIW) has 6 years of Total Current Liabilities data on file, last reported at $11.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities changed 0.28% year-over-year to $11.8 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (changed 0.28% YoY), and the FY2025 full-year result was $11.5 million, up 12.43% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $11.8 million, up from $11.5 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $32.4 million in Q4 2022 and bottomed at $1.7 million in Q2 2022.
• The 5-year median for Total Current Liabilities is $10.2 million (2024), against an average of $10.3 million.
• The widest annual swing landed in 2022, when Total Current Liabilities surged 1920.27%; it then plunged 54.61% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $32.4 million in 2022, then slumped by 54.61% to $14.7 million in 2023, then sank by 30.36% to $10.2 million in 2024, then climbed by 12.43% to $11.5 million in 2025, then climbed by 2.5% to $11.8 million in 2026.
• The last three Total Current Liabilities figures came in at $11.8 million (Q1 2026), $11.5 million (Q4 2025), and $10.9 million (Q3 2025), per Business Quant data.

Peer Comparison